Alphabet soup, treatment setbacks and Black Friday(s)

As the market reverses lower, some investors could be misreading the signs when picking a letter to describe the economic recovery. We’ll explain.

Plus, Eli Lilly is pausing its Covid antibody drug trial, now the second virus treatment setback this week. Should investors rethink their strategy in the healthcare space? We’ll debate.

And, Walmart is throwing out its Black Friday playbook, and breaking it up into three separate sales events. Could this be a winning strategy? We explore in Rapid Fire.